Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

27 Sep 2016 14:51

DIRECTOR DEALINGS: Vectura Chairman Buys 80,000 Shares

Read more
7 Sep 2016 08:09

Vectura Group gains from Skyepharma merger as it raises expectations

(ShareCast News) - Inhaled airways disease focused business Vectura Group raised expectations for 2016 as it said it is making progress with the June Skyepharma merger. The company raised revenue expectations for the nine month period ended 31 December, due to strong growth from its partnered market

Read more
7 Sep 2016 07:33

LONDON MARKET OPEN: Mixed Open; Ashtead Leads Gainers, Worldpay Losers

Read more
5 Sep 2016 07:42

Breezhaler better than Seretide, says Vectura

(ShareCast News) - Inhaled airways disease focused pharmaceuticals company Vectura Group confirmed an announcement from its alliance partner Novartis on Monday, that new analyses from the head-to-head FLAME study confirmed that Ultibro Breezhaler is a "more effective option" for patients at risk of

Read more
31 Aug 2016 11:35

Vectura inhaler collaboration with Novartis improves treatment persistence

(ShareCast News) - Novartis has published data about a respiratory drug combination delivered using an inhaler designed in collaboration with Vectura that shows patients are twice as likely to persist with treatment over 12 months than with a popular product already on the market. Patients using Nov

Read more
30 Aug 2016 07:35

LONDON MARKET OPEN: Bunzl Leads Gainers As Miners Drag On FTSE 100

Read more
30 Aug 2016 07:31

Vectura Group Says Flutiform Has Failed To Meet Primary Endpoint

Read more
22 Aug 2016 14:30

Investec resumes coverage on Vectura at 'buy'

(ShareCast News) - Investec resumed coverage on Vectura at 'buy' with a 200p price target following completion of the SkyePharma deal. "In our view, the benefits from a broader royalty base, improved cash flows, as well as an enhanced competency set, are yet to be fully reflected in the share price,

Read more
5 Aug 2016 07:08

Vectura to receive milestone payment for EXPAREL

(ShareCast News) - Inhaled airways disease focused company Vectura Group announced on Friday that a sales milestone receipt of $8m has been triggered following confirmation by Pacira Pharmaceuticals that worldwide annual net sales of EXPAREL, on a cash received basis to 30 June, were above $250m. Th

Read more
20 Jul 2016 12:42

Your inhaler's watching you: drugmakers race for smart devices

* Digitally connected devices aim to track medicine use * GSK, AstraZeneca, Novartis all working on smart inhalers * Innovation drive comes as sector faces growing competition By Ben Hirschler LONDON, July 20 (Reuters) - Makers of inhalers to treat asthma and chronic lung

Read more
6 Jul 2016 08:32

BROKER RATINGS SUMMARY: Macquarie Raises Banks, HSBC Lowers Grocers

Read more
1 Jul 2016 06:33

Vectura Group Says Lyon Manufacturing Facility Lease Returned

Read more
28 Jun 2016 09:13

Vectura Says Partner Ablynx Exercises Commercial Licence Option

Read more
20 Jun 2016 13:41

Director dealings: Skyepharma CFO gets cash injection from Vectura merger

(ShareCast News) - Skyepharma's chief financial officer Andrew Derodra has pocketed a healthy cash injection after the completion of the merger with Vectura. Derodra exercised nil-cost options over 150,000 Skyepharma shares that were a bonus in his long-term incentive plan that vested on completion

Read more
10 Jun 2016 16:08

LONDON MARKET CLOSE: Global Economy, EU Vote Worries Hit Sentiment

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.